New study aims to predict organ damage in cancer patients on immunotherapy
NCT ID NCT07131007
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study enrolls 2000 cancer patients receiving immune checkpoint inhibitors. Researchers collect blood, urine, and stool samples before and after treatment to analyze genes, proteins, and other markers. The goal is to create a system that warns doctors early if a patient's organs are at risk of damage from immunotherapy. No new treatments are tested; this is purely observational.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a system that predicts organ damage early in cancer patients receiving immunotherapy, improving safety.
What could go wrong
This is an observational study, not a treatment trial. The system may not be accurate enough for real-world use, and results may take years to apply.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fourth Hospital of Hebei Medical University
RECRUITINGShijiazhuang, Hebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••